RESUMEN
The NR4A nuclear receptor family (NR4As), encompassing NR4A1, NR4A2, and NR4A3, exerts pivotal roles in cellular processes through intricate expression patterns and interactions. Despite the influence of some NR4As on anterior pituitary functions regulated by the hypothalamus, their physiological expression patterns remain unclear. In our prior work, we demonstrated the specific upregulation of NR4A3 in the rat anterior pituitary gland during the proestrus afternoon, coinciding with a gonadotropin surge. In this study, we investigated changes in pituitary Nr4a gene expression throughout the estrous cycle in rats and a gonadotropin surge-induced model. Nr4a1 and Nr4a2 gene expression significantly increased during proestrus, aligning with previous observations for Nr4a3. Furthermore, prolactin gene expression increased sequentially with rising Nr4a gene expression, while thyroid-stimulating hormone beta gene expression remained stable. Immunohistochemistry revealed a widespread and differential distribution of NR4A proteins in the anterior pituitary, with NR4A1 and NR4A3 being particularly abundant in thyrotrophs, and NR4A2 in gonadotrophs. In estrogen-treated ovariectomized rats, elevated luteinizing hormone secretion corresponded to markedly upregulated expression of Nr4a1, Nr4a2, and Nr4a3. In gonadotroph and somatomammotroph cell lines, gonadotropin- and thyrotropin-releasing hormones transiently and dose-dependently increased the expression of Nr4a genes. These findings suggest that hypothalamic hormone secretion during proestrus may induce the parallel expression of pituitary Nr4a genes, potentially influencing the pituitary gene expression program related to endocrine functions before and after ovulation.
Asunto(s)
Adenohipófisis , Hipófisis , Femenino , Ratas , Animales , Proestro/fisiología , Hipófisis/metabolismo , Adenohipófisis/metabolismo , Hormona Liberadora de Gonadotropina/metabolismo , Gonadotropinas/metabolismoRESUMEN
Multifocal lymphangioendotheliomatosis with thrombocytopenia is a rare disease characterized by progressive multiple vascular lesions and is accompanied by thrombocytopenia. The precise diagnosis of this disease is frequently difficult because of the heterogeneity of the clinical symptoms. We report a case of a male infant who presented with severe thrombocytopenia induced by local inflammation. In addition, enlargement of the extremities with soft tissue and bone involvement without gastrointestinal bleeding was observed. The thrombocytopenia resolved after a combination therapy of sirolimus and prednisolone. Our finding that plasma angiopoietin-2 concentrations reflected the disease status suggests its utility as a biomarker of Multifocal lymphangioendotheliomatosis with thrombocytopenia.
Asunto(s)
Trastornos de la Coagulación Sanguínea , Trombocitopenia , Lactante , Humanos , Masculino , Trombocitopenia/complicaciones , Trombocitopenia/tratamiento farmacológico , Trombocitopenia/diagnóstico , Hemorragia Gastrointestinal/complicaciones , Trastornos de la Coagulación Sanguínea/tratamiento farmacológico , Sirolimus/uso terapéutico , Prednisolona/uso terapéuticoRESUMEN
INTRODUCTION: The extravehicular activity suit currently used by the United States in space includes a liquid cooling and ventilation garment (LCVG) that controls thermal conditions. Previously, we demonstrated that self-perspiration for evaporative cooling (SPEC) garment effectively lowers skin temperature without raising humidity in the garment. However, the cooling effect is delayed until a sufficient dose of water permeates and evaporates. In the present study, we hypothesized that wearer-controlled vaporization improves the cooling effect. METHODS: Six healthy subjects rode a cycle ergometer under loads of 30, 60, 90, and 120 W for durations of 3 min each. Skin temperature and humidity on the back were measured continuously. Subjects wore and tested three garments: 1) a spandex garment without any cooling device (Normal); 2) a simulated LCVG (s-LCVG) or spandex garment knitted with a vinyl tube for flowing and permeating water; and 3) a garment that allowed wearer-controlled vaporization (SPEC-W). RESULTS: The use of s-LCVG reduced skin temperature by 1.57 ± 0.14°C during 12 min of cooling. Wearer-controlled vaporization of the SPEC-W effectively and significantly lowered skin temperature from the start to the end of cycle exercise. This decrease was significantly larger than that achieved using s-LCVG. Humidity in the SPEC-W was significantly lower than that in s-LCVG. DISCUSSION: This preliminary study suggests that SPEC-W is effective in lowering skin temperature without raising humidity in the garment. The authors think it would be useful in improving the design of a cooling system for extravehicular activity.Tanaka K, Nagao D, Okada K, Nakamura K. Cooling effects of wearer-controlled vaporization for extravehicular activity. Aerosp Med Hum Perform. 2017; 88(4):418-422.